CYTOKINETICS, INCORPORATED Operating Lease, Liability, Noncurrent
CYTOKINETICS, INCORPORATED (CYTK) had Operating Lease, Liability, Noncurrent of $102.43 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-08-06
- 2026-06-30: Operating Lease, Liability, Noncurrent $102.43M.
- 2026-03-31: Operating Lease, Liability, Noncurrent $105.23M.
- 2025-12-31: Operating Lease, Liability, Noncurrent $107.97M.
- 2025-09-30: Operating Lease, Liability, Noncurrent $110.66M.
| Period end | Operating Lease, Liability, Noncurrent | Operating Lease, Liability, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $102.43M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $105.23M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $107.97M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $110.66M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $111.03M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $113.35M 10-Q · filed 2025-05-06 | |
| 2024-12-31 | $112.58M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $114.75M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $116.72M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $118.55M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $120.43M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $122.22M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $123.83M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $125.34M 10-Q · filed 2023-05-05 | |
| 2022-12-31 | $126.89M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $114.41M 10-Q · filed 2022-11-04 | |
| 2022-06-30 | $112.73M 10-Q · filed 2022-08-05 | |
| 2022-03-31 | $112.02M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $112.23M 10-K · filed 2023-03-01 | |
| 2021-03-31 | $85.63M 10-Q · filed 2021-05-07 | |
| 2020-12-31 | $440.00K 10-K · filed 2022-02-25 | |
| 2020-06-30 | $591.00K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $1.77M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $2.19M 10-Q · filed 2020-08-07 | |
| 2019-09-30 | $3.26M 10-Q · filed 2019-11-01 | |
| 2019-06-30 | $4.29M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $5.27M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $771.00K 10-K · filed 2020-03-04 | $0.00 10-Q · filed 2019-05-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |